Arkolith/Insider Trading/RLAY/Form 4

Patel Sanjiv

President and CEO, DirectorRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Jul 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$944K
Net Open-Market Flow
-$944K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 7, 2026Sell(S)48K$19.58$944K616K
Jun 30, 2026Grant(A)3K$6.95$21K664K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-298681) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML